Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Signature Therapeutics patents

List of Signature Therapeutics patents

List of Suncor patents

List of Sandoz patents

List of FOREO patents

List of companies in Geode Capital Management's investment portfolio

List of funding rounds for Vape (company)

Patents where

Current Assignee

Name

is

Signature Therapeutics

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10028945 Compositions comprising enzyme-cleavable ketone-modified opioid prodrugs and optional inhibitors thereof	Patent 10028945 was granted and assigned to Signature Therapeutics on July, 2018 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	10028945	July 24, 2018
	‌ US Patent 8962547 Compositions comprising enzyme-cleavable oxycodone prodrug	Patent 8962547 was granted and assigned to Signature Therapeutics on February, 2015 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	8962547	February 24, 2015
	‌ US Patent 8173849 Therapeutic compounds	Patent 8173849 was granted and assigned to Signature Therapeutics on May, 2012 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	8173849	May 8, 2012
	‌ US Patent 8163701 Prodrugs of active agents	Patent 8163701 was granted and assigned to Signature Therapeutics on April, 2012 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	8163701	April 24, 2012
	‌ US Patent 9095627 Opioid prodrugs with heterocyclic linkers	Patent 9095627 was granted and assigned to Signature Therapeutics on August, 2015 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	9095627	August 4, 2015
	‌ US Patent 8217005 Controlled release of phenolic opioids	Patent 8217005 was granted and assigned to Signature Therapeutics on July, 2012 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	8217005	July 10, 2012
	‌ US Patent 8350097 Therapeutic compounds	Patent 8350097 was granted and assigned to Signature Therapeutics on January, 2013 by the United States Patent and Trademark Office.		Signature Therapeutics		United States Patent and Trademark Office	8350097	January 8, 2013

7 results

0 selected

7 results

0 selected